| Company Name: |
Shenzhen SUNGENING Bio-Medical Co., Ltd.
|
| Tel: |
0755-28967200 13631290199 |
| Email: |
wxf@sungening.com |
| Products Intro: |
Product Name:Dihydroergotamine Mesilate Impurity E
CAS:17479-19-5
Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:Dihydroergocristine
CAS:17479-19-5
Purity:溶液 Package:5mg；10mg；20mg；50mg；100mg；200mg
|
| Company Name: |
Shaanxi Dideu Newmaterial Co., Ltd.
|
| Tel: |
029-63373950 15353716720 |
| Email: |
1052@dideu.com |
| Products Intro: |
Product Name:Dihydroergocristine
CAS:17479-19-5
Purity:99% Package:25KG
|
| Company Name: |
Cdreamlab (Hubei) Technology Co., LTD
|
| Tel: |
0717-6300888 18062399888 |
| Email: |
service@cdreamlab.com |
| Products Intro: |
Product Name:dihydroergocristine
CAS:17479-19-5
Purity:>=95% Package:100G;10KG;100KG
|
|
| | dihydroergocristine Basic information |
| Product Name: | dihydroergocristine | | Synonyms: | dihydroergocristine;9,10-Dihydroergocristine;9,10α-Dihydro-12'-hydroxy-2'-isopropyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione;9,10α-Dihydro-12'-hydroxy-2'-isopropyl-5'α-benzylergotaman-3',6',18-trione;Dihydroergocristin;NSC 409663;Dihydro Ergotamine Mesylate Impurity E;Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'α,10α)- | | CAS: | 17479-19-5 | | MF: | C35H41N5O5 | | MW: | 611.73 | | EINECS: | 241-493-4 | | Product Categories: | | | Mol File: | 17479-19-5.mol |  |
| | dihydroergocristine Chemical Properties |
| Melting point | 199℃ (decomposition) | | Boiling point | 899.3±65.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | pKa 6.89±0.07(H2O t=24 I≤0.01) (Uncertain) |
| | dihydroergocristine Usage And Synthesis |
| Definition | ChEBI: Ergocristine in which a single bond replaces the double bond between positions 9 and 10. It is used as the mesylate salt for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. |
| | dihydroergocristine Preparation Products And Raw materials |
|